Cidara Therapeutics (CDTX) Insider Trading & Ownership $22.69 -1.31 (-5.46%) Closing price 04:00 PM EasternExtended Trading$21.96 -0.73 (-3.22%) As of 04:22 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Cidara Therapeutics (NASDAQ:CDTX) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage7.64%Number OfInsiders Buying(Last 12 Months)1Amount OfInsider Buying(Last 12 Months)$105,680.00Number OfInsiders Selling(Last 12 Months)3Amount OfInsider Selling(Last 12 Months)$86,231.88 Get CDTX Insider Trade Alerts Want to know when executives and insiders are buying or selling Cidara Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address CDTX Insider Buying and Selling by Quarter Cidara Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails3/11/2025Leslie TariInsiderSell1,773$21.96$38,935.08 3/11/2025Shane WardCOOSell1,664$21.96$36,541.44 9/11/2024Taylor SandisonInsiderSell924$11.64$10,755.36 6/7/2024Jeffrey SteinCEOBuy8,000$13.21$105,680.00 (Data available from 1/1/2013 forward) CDTX Insider Trading Activity - Frequently Asked Questions Who is on Cidara Therapeutics's Insider Roster? The list of insiders at Cidara Therapeutics includes Jeffrey Stein, Leslie Tari, Paul Daruwala, Preetam Shah, Shane Ward, and Taylor Sandison. Learn more on insiders at CDTX. What percentage of Cidara Therapeutics stock is owned by insiders? 7.64% of Cidara Therapeutics stock is owned by insiders. Learn more on CDTX's insider holdings. Which Cidara Therapeutics insiders have been buying company stock? The following insiders have purchased CDTX shares in the last 24 months: Jeffrey Stein ($153,680.00), and Leslie Tari ($9,700.00). How much insider buying is happening at Cidara Therapeutics? Insiders have purchased a total of 11,000 CDTX shares in the last 24 months for a total of $163,380.00 bought. Which Cidara Therapeutics insiders have been selling company stock? The following insiders have sold CDTX shares in the last 24 months: Leslie Tari ($70,555.48), Preetam Shah ($12,676.40), Shane Ward ($50,249.64), and Taylor Sandison ($10,755.36). How much insider selling is happening at Cidara Therapeutics? Insiders have sold a total of 8,304 Cidara Therapeutics shares in the last 24 months for a total of $144,236.88 sold. Cidara Therapeutics Key ExecutivesDr. Jeffrey L. Stein Ph.D. (Age 69)President, CEO & Executive Director Compensation: $603.7kMr. Shane M. Ward (Age 49)Chief Legal Officer,Corporate Secretary & COO Compensation: $464.54k1 recent tradesDr. Taylor Sandison M.D. (Age 52)M.P.H., Chief Medical Officer Compensation: $497kDr. Kevin M. Forrest Ph.D. (Age 47)Founder and Chief Strategy Officer Compensation: $333.31kDr. Preetam Shah M.B.A. (Age 51)Ph.D., CFO, Chief Business Officer & Principal Accounting Officer Compensation: $577.85kMs. Allison Lewis CCPSPHR, Senior Vice President of People & CultureDr. Leslie Tari Ph.D. (Age 56)Chief Scientific Officer Compensation: $845.1kMs. Laura A. NavaltaSenior Vice President of Clinical OperationsDr. Nicole Davarpanah J.D.M.D., Senior VP of Translational Research & Development More Insider Trading Tools from MarketBeat Related Companies Dyne Therapeutics Insider Buying ANI Pharmaceuticals Insider Buying Ocular Therapeutix Insider Buying Amphastar Pharmaceuticals Insider Buying 89bio Insider Buying Aurinia Pharmaceuticals Insider Buying Gyre Therapeutics Insider Buying Mineralys Therapeutics Insider Buying Wave Life Sciences Insider Buying Phibro Animal Health Insider Buying Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Meta's Institutional & Insider Data Fuels Bulls Despite DisparityTurbulence for Joby Shares: What's Behind the Recent Dip?UnitedHealth Insiders Double Down: Is UNH Stock a Value Play?Sprouts Stock: Insider Sales, But Strong Bullish Signals5 Hot Small-Cap Insiders Bought at the Peak of Tariff Fears This page (NASDAQ:CDTX) was last updated on 5/28/2025 by MarketBeat.com Staff From Our PartnersJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredTrump Predicts Dollar DownfallREAD THIS VERY CAREFULLY: If you have $100,000 or more saved for retirement, this may make you VERY angry... ...Augusta Precious Metals | SponsoredElon’s 2025 Silver Crisis (What It Means for You)Elon Musk is back in the spotlight—this time for fueling a global scramble for silver. Tesla's relentless p...GoldenCrest Metals | SponsoredBanks aren’t ready for this altcoin—are you?While everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly po...Crypto 101 Media | SponsoredA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredF1 Engineering Powers This Electric Marine MotorThe future of marine propulsion has arrived - powered by F-1 grade engineering. In collaboration with McLar...The Tomorrow Investor | SponsoredTrump Quietly Planning $15 Trillion Crypto ShockerMost investors are still unaware, but I believe a new White House action may have quietly opened the floodgate...Paradigm Press | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Robots aren't coming to America in 2025. They are already here. Oxford Economics says, "The Robotics Rev...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cidara Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cidara Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
